Back

Influence of pretreatment with aspirin or statins or both on clinical presentation as well as infarct size and inflammation in patients with de novo acute coronary syndromes

26 August 2018 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Coronary artery disease - Epidemiology and outcomes 2 Pharmacotherapy ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Lukas Weidmann

University Heart Center, Zurich (Switzerland)

9 More presentations in this session

Presentation thumbnail
Doctor R. Rossini (Cuneo, IT)
Abstract Slides
Presentation thumbnail
Associate Professor B. Zheng (Beijing, CN)
Abstract
Presentation thumbnail
Doctor F. Loncaric (Zagreb, HR)
Abstract Slides
Presentation thumbnail
Presentation thumbnail
Doctor E. Park (Seoul, KR)
Abstract

Access the full session

Session thumbnail
Poster Session 3 - Coronary artery disease - Epidemiology and outcomes 2

The Event

Event poster

ESC Congress 2018

26 August 2018 14:00 CET
You may be interested in
thumbnail
Webinar
Aspirin treatment for mitigating thrombotic risk across the cardiovascular risk continuum
6 July 2023
thumbnail
Congress Presentation
Two week interruption of statin therapy results in an exaggerated inflammatory phenotype in young myocardial infarction patients without standard modifiable risk factors
28 August 2022
thumbnail
Congress Presentation
Infarct size following loading with ticagrelor/prasugrel versus clopidogrel in ST-segment elevation myocardial infarction
28 August 2020
thumbnail
Congress Presentation
Residual platelet activity and systemic inflammation in patients with chronic coronary syndrome in the context of aspirin monotherapy.
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources